Skip to content

Artal Group S.A.

Follow

13F filer, CIK 1053906, LUXEMBOURG, Luxembourg

Artal Group S.A. reported $1,010,581,941 across 2 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001053906-26-000006

Period
2026-03-31
Reported value
$1.01B
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LXRXadded+18,553,846$28.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001053906-26-000006, largest first. % of portfolio is the value over $1,010,581,941, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 17,507,990 shares; 2024Q4: 9,507,990 shares; 2025Q1: 9,507,990 shares; 2025Q2: 9,507,990 shares; 2025Q3: 9,507,990 shares; 2025Q4: 9,507,990 shares; 2026Q1: 9,507,990 shares 9,507,990$769M76.11%0Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 136,180,481 shares; 2024Q4: 136,180,481 shares; 2025Q1: 136,180,481 shares; 2025Q2: 136,180,481 shares; 2025Q3: 136,180,481 shares; 2025Q4: 136,180,481 shares; 2026Q1: 154,734,327 shares 154,734,327$241M23.89%+18,553,846Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001053906-26-000006 base2026-05-14acceptance time not in the bulk data set